Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WESTLAKE CORP Director's Dealing 2017

Feb 22, 2017

30551_dirs_2017-02-22_a883d812-7916-453a-a190-ad90d8864687.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WESTLAKE CHEMICAL CORP (WLK)
CIK: 0001262823
Period of Report: 2017-02-17

Reporting Person: Bender Mark Steven (Sr VP, CFO and Treasurer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-17 Employee Option (right to buy) $61.865 A 20995 Acquired 2027-02-17 Common Stock (20995) Direct
2017-02-17 Restricted Stock Units $ A 5375 Acquired Common Stock (5375) Direct

Footnotes

F1: The stock options are exercisable in three installments of 33%, 33% and 34% on February 17, 2018, 2019 and 2020, respectively.

F2: Each restricted stock unit represents a contingent right to receive one share of Westlake Chemical Corporation common stock.

F3: The restricted stock units will vest 3 years from the date of grant (February 17, 2020).